Immediate Impact

8 by Nobel laureates 23 from Science/Nature 73 standout
Sub-graph 1 of 23

Citing Papers

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome
2019 Standout

Works of Finn Wislöff being referenced

A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)
2005

Author Peers

Author Last Decade Papers Cites
Finn Wislöff 2398 980 1206 1049 99 4.3k
Antonio De Vivo 1879 423 907 920 88 3.8k
J. S. Malpas 1733 423 1906 1347 109 5.4k
M. Greaves 2618 897 325 285 115 5.3k
Frank Bridoux 1540 484 671 3224 162 5.5k
W M Crist 1835 665 2010 1435 75 6.0k
Howard J. Weinstein 2179 229 1223 837 121 5.3k
Brigitte Bader‐Meunier 1843 1728 300 1535 206 5.6k
Graça M. Dores 817 287 2835 1542 83 7.9k
Roberto Stasi 6780 491 1125 925 162 9.4k
Marc B. Garnick 592 360 1171 805 132 4.9k

All Works

Loading papers...

Rankless by CCL
2026